News
We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.
2d
Zacks Investment Research on MSNMRNA Stock Jumps on CDC's Revised RSV Vaccine RecommendationsShares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...
Two young elephants at the Cincinnati Zoo, Sanjay and Kabir, overcame a deadly virus thanks to a new vaccine introduced to ...
Two young male elephants, Sanjay and Kabir, who were vaccinated in 2024, later tested positive for Elephant Endotheliotropic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results